Jahan Marcu

Photo of Dr. Jahan Marcu

Jahan Marcu, Ph.D., has over 15 years of experience in academic research, industry, and government relations. Dr. Marcu is presently the Chief Operations Officer, Director of Experimental Pharmacology and Behavioral Research at International Research Center on Cannabis and Mental Health (IRCCMH), which he co-founded. Dr. Marcu is the former Chief Science Officer at Americans for Safe Access (ASA) and former Director of ASA’s Patient Focused Certification program, which is a health and safety oversight program that assesses regulatory compliance at cannabis operations. Dr. Marcu published the first direct measurements of THC and CBD synergy, for which he received the Billy Martin research award from the International Cannabinoid Research Society. His Ph.D. focused on solving the structure and function of the CB1 receptor as well as investigating the role of the endocannabinoid system in bone. He has also developed pharmacogenomics testing technology, used commercially and in research studies to predict drug-drug interactions with cannabis, as well as using the technology to guide dosing and administration forms for patients.

Cannabis & Cancer

Cannabis and cancer studies

Millions of Americans now have access to medical marijuana. When it comes to cancer treatment, beyond helping with the nausea of chemotherapy, there is strong scientific evidence of a deeper benefit of using cannabis with conventional therapies.

Synergy: The interaction of elements that when combined produce a total effect that is greater than the sum of the individual elements, contributions, etc.